Search results
Results from the WOW.Com Content Network
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4]
Antistasin, the first discovered naturally occurring direct Xa inhibitor Rivaroxaban, the first synthetic direct Xa inhibitor marketed as a drug Prior to the introduction of direct factor Xa inhibitors, vitamin K antagonists such as warfarin were the only oral anticoagulants for over 60 years, and together with heparin have been the main blood ...
Start downloading a Wikipedia database dump file such as an English Wikipedia dump. It is best to use a download manager such as GetRight so you can resume downloading the file even if your computer crashes or is shut down during the download. Download XAMPPLITE from (you must get the 1.5.0 version for it to work). Make sure to pick the file ...
Download QR code; In other projects ... English: Chemical formula of rivaroxaban (original brand name Xarelto, ... Usage on nl.wikipedia.org Rivaroxaban;
This page was last edited on 4 November 2019, at 16:51 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Date/Time Thumbnail Dimensions User Comment; current: 21:42, 14 May 2015: 6,222 × 3,580 (36 KB): Fuse809 {{Information |Description=Skeletal structure of rivaroxaban.
Andexanet alfa is a biologic agent, a recombinant modified version of human activated factor X (FXa). [17] Andexanet alfa differs from native FXa due to the removal of a 34 residue fragment that contains the Gla domain. This modification reduces andexanet alfa's anticoagulant potential.